Nanalyze

Nanalyze

By NanalyzeBusinessInvesting
Download on the App Store

Nanalyze episodes

  • NVIDIA stock isn't overvalued. Here's why.

    NVIDIA stock has been rallying lately due to extraordinary demand for their GPUs for AI applications such as ChatGPT. With the stock up over 200% in the past year versus a 40% return of the Nasdaq, investors may be left wondering whether NVDA stock is overvalued. Today we'll analyze NVIDIA stock using our simple valuation ratio as well as the traditional P/E ratio, and we'll do it step-by-step so you can do the same. Turns out you can make a case for NVIDIA stock not being overvalued using the middle of guidance given by nearly 40 analysts who follows $NVDA. That's by comparing it to a benchmark such as the Nasdaq. Watch the video to see how we did this, then let us know if you think NVDA stock is overvalued.
    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/PvVkYfWIMpc.

    15 min
  • What most people don't know about JEPI

    Everyone is talking about JEPI, few are talking about holding JP Morgan's Equity Premium Income ETF is a bad idea. That's because 80% of the "income" being generated by this active investment strategy comes from selling covered calls. They're not covered calls, they're equity linked notes ELNs, people will say. Correct. JEPI's fund managers don't log into Robinhood and sell covered calls all day. An ETF with $32 billion in assets needs to do things differently which is why they use ELNs to generate income which is actually a play on volatility. When we understand how covered calls work - they cap returns on the upside - then it's intuitive why JEPI's total return cannot outperform the market in the long term, and the JEPI ETF prospectus tells us that. People who argue that short-term investors can hold it for income are missing the point - this asset's total return is less than simply holding a broad market ETF. If you want income, don't look for instant gratification. A dividend growth ETF or strategy like SCHD allows investors an initial lower yield, but will quickly grow to exceed JEPI's yield in the long term. Don't invest in things you don't understand, and with JEPI there's only one sure thing - the fund managers (who have no real incentive to maximize total return as they explicitly tell you) are laughing all the way to the bank.
    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/nd9AmdTd0g0.

    19 min
  • Wolfspeed's Stock Crash: Bargain or Bust?

    Wolfspeed stock keeps hitting new lows as investors ask an important question. Is WOLF stock a good buy or a trap? We start by looking at the broader silicon carbide SiC thesis with a look at how China may become a major player with lots of SiC wafer production coming online. Then, we touch on the Tesla announcement of plans to cut back on silicon carbide usage in their electric vehicles, and how that may not matter all that much provided the costs of silicon carbide can fall enough to spur adoption. That brings us to the 8-inch wafer thesis which is what attracted investors to Wolfspeed stock in the first place. Well, that and the WOLF stock price which is just cratering, and the reason for that is poor execution. What key metrics should Wolfspeed investors watched? Glad you asked Johnny. That's in the video too which you need to go watch ASAP. Aight?
    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/rG4OvQopGnc.

    18 min
  • New Gene Editing Stock [Should We Buy?]

    Gene editing investors may soon have one more stock to choose from. A gene-editing company called Metagenomi $MGX uses AI to discover novel CRISPR gene editing methods from nature and they're planning to have an IPO. We start by looking at all the current players according to the IPO S-1 filing, then describe what the ideal gene editing business model looks like. Then, we describe how MGX plans to compete against CRISPR CAS9 competitors like CRISPR Therapeutics and Intellia Therapeutics. Basically, they have better technology - a platform that uses AI to discover gene editing tools - and they believe the intellectual property constraints won't apply to them. Would be buy Metagenomi stock? How about we wait for the IPO to happen first ;) We list out some milestones for gene editing investors to watch and look at how we expect the company to progress. Seems like there's never been a better time to invest in gene editing, but it's anybody's game with all the external risks. And there can be more than one winner.
    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/8k83pekwtcU.

    14 min
  • Why Indian Stocks Are So Risky

    Investing in Indian stocks is full of dangerous pitfalls, both for Indian domestic investors and especially foreign investors who are entering a market they know little about. The ugly truth is that Indian business culture has a reputation for scams that are pervasive across financial institutions, banks, startups, fintech, and publicly traded companies. To avoid all the bad apples, you'll need a big basket of both good and bad apples to diversify away company specific risk. India ETFs are the perfect answer, so we look at the iShares MSCI India ETF INDA and the Franklin FTSE India ETF FLIN, both of which have some appeal. Ultimately, it comes down to expense ratios which are the single most important predictor of returns in the long run. For that reason, we'd learn towards investing in... well, you'll have to watch the video to find out!
    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/fTQpVT7mzjU.

    16 min
  • Confused about dividend taxes? Watch this.

    SCHD investors have a lot of questions about dividend taxes, and it doesn't need to be so complicated. We explain in simple terms how qualified vs non qualified dividends are taxed with examples provided by someone else who did the heavy lifting. Does $SCHD offer qualified or non qualified dividends? To answer that question we need to look at the underlying index for SCHD which in fact makes it a point to exclude REITs which are the most common asset dividend growth investors will come across that falls into the nonqualified dividend bucket. Why are qualified dividends preferred? It's because they receive more favorable tax treatment. Want to understand what that looks like? Just watch the video as we walk you through - using simple examples - the two types of taxation methods used for qualified and non qualified dividends (ordinary income taxation and capital gains taxation). This is a must watch video for anyone confused about dividend taxation, for SCHD and other dividend stocks and ETFs, and looking for a simple guide.

    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/7SEFiAvdKmA.

    19 min
  • Here’s Why PYPL Stock Sucks

    PayPal stock $pypl is trading down 20% since the last time we checked in - 18 months ago - at which time we said pypl stock wouldn't be interesting at any price. That's only because we invest in two areas - disruptive growth and dividend growth - and PayPal's days of disruption appear over. The problem PayPal has is trying to resurrect growth as management talks about focusing on current accounts. That land-and-expand strategy comes with lowering take rates, so even through transaction volumes are increasing, revenue growth isn't keeping up at the same pace. PayPal investors who look back at the lofty share prices of old need to remember those were justified by management's claim of hitting $50 billion in revenues by next year. That doesn't appear to be happening as 2023 expects to see around $29 billion. PayPal's problem is that the market is now seeing them as more of a value stock than a growth stock.

    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/upBa_o4cGZE.⁠

    16 min
  • Investing in EV stocks? [Watch this first.]

    EV stocks have destroyed retail investors with only two names out there worth looking at - BYD and Tesla. Unfortunately, there are some reasons not to invest in both which we discuss. Instead, why not consider investing in the components of electric vehicles - in particular, EV chips. While autonomous driving sensors (like those from Mobileye MBLY) may be a way to invest in autonomy across all vehicle types, we're mainly interested in semiconductor companies making chips that exclusively used by electric vehicles. Based on this thesis, we've come up with 5 EV chip stocks that may merit a closer look - names like Wolfspeed WOLF and Indie Semiconductor INDI which both happen to be very popular among retail investors. If you're thinking about investing in electric vehicle stocks, you'll want to give this video a watch first.

    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/_xMKr0dTIg8.

    17 min
  • The [Best Dividend ETF] for 2024

    The best dividend growth ETF comes down to SCHD vs DGRO - Charles Schwab vs iShares. That's after we vetted four other dividend ETFs with the lowest expense ratios. SCHD not only charges less than DGRO, they also have twice the assets which means more leeway for future fee reductions. It all comes down to the index each ETF tracks and their underlying methodologies. Performance, especially in the short term, means very little. The winner is very clear. It's the dividend ETF with the highest yield and dividend growth. Without a doubt, we believe the best dividend growth ETF out there is... [Drum roll.] Go watch the video, please.

    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/qDAj5WVy198.

    17 min
  • Why Wall Street Is Completely Wrong About IBM

    IBM stock has performed poorly over the years as the company's two key metrics - revenue and free cash flow - stagnate. That's all water under the bridge as IBM has reinvented themselves now with (checks notes) yet another pivot into AI. IBM's AI creation Watson is now watsonx, and that subtle name change is supposed to make us forget about the Watson Health disaster. Based on comments in the latest earnings call, generative AI and Watson brought in $400 million in revenues last quarter, but that will be recognized over 12-24 months. In the meantime, the "Data and AI" revenue segment grew just 5% last year. IBM is no AI stock, but they are forecasting $12 billion in free cash flow next year which saw their share price hit 10-year highs. Now maybe they can start growing that dividend a bit more than just the paltry 1.3% we've seen over the past 5 years. Here's to hoping we're wrong about IBM's AI success story being all dough and little show.

    Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/VCPitfzj5oQ.

    14 min

About Nanalyze

From the publisher's feed

Nanalyze is a media and research firm founded by finance professionals with decades of experience. We share insights about disruptive technology stocks in a language that is future-proof and easy to understand.

More shows like Nanalyze

Motley Fool Hidden Gems Investing by The Motley Fool

Motley Fool Hidden Gems Investing

3,153 Listeners

The Investor's Podcast (We Study Billionaires)  - The Investor’s Podcast Network by The Investor's Podcast Network

The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network

3,328 Listeners

Investing Insights by Morningstar, Ivanna Hampton, Sarah Hansen

Investing Insights

521 Listeners

Macro Voices by Erik Townsend

Macro Voices

3,054 Listeners

The Pomp Podcast by Anthony Pompliano

The Pomp Podcast

1,832 Listeners

Investing With IBD by Investor's Business Daily

Investing With IBD

381 Listeners

The Joseph Carlson Show by The Joseph Carlson Show

The Joseph Carlson Show

243 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

10,183 Listeners

Barron's Streetwise by Barron's

Barron's Streetwise

1,551 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

553 Listeners

The Memo by Howard Marks by Oaktree Capital Management

The Memo by Howard Marks

438 Listeners

Barron's Live by Barron's Live

Barron's Live

212 Listeners

Bloomberg Talks by Bloomberg

Bloomberg Talks

20 Listeners

The Morning Filter by Morningstar, Susan Dziubinski - Investment Specialist, Dave Sekera - Chief U.S. Markets Strategist

The Morning Filter

48 Listeners

The Real Eisman Playbook by Steve Eisman

The Real Eisman Playbook

225 Listeners